Why publish your research with STEM CELLS Translational Medicine®?
STEM CELLS Translational Medicine is a monthly, peer-reviewed, online only, and fully open access journal. STEM CELLS Translational Medicine works to advance the utilization of cells for clinical therapy. By bridging stem cell molecular and biological research and helping speed translations of emerging lab discoveries into clinical trials, the journal helps move applications of these critical investigations closer to accepted best patient practices and ultimately improve outcomes.
The journal encourages original research articles and concise reviews describing laboratory investigations of stem cells including their characterization and manipulation, and the translation of their clinical aspects from bench to patient care. STEM CELLS Translational Medicine covers all aspects of translational cell studies, including bench research, first-in-human case studies, and relevant clinical trials.
Read on to learn why STEM CELLS Translational Medicine is the perfect home for your research.
Simple submission
STEM CELLS Translational Medicine is format-neutral at initial submission, which means that manuscripts do not need to be formatted according to specific journal guidelines to be considered for review. This allows for a more seamless submission process without tedious formatting.
Rapid publication
Fully copyedited and typeset manuscripts are published online with a DOI in about 20 days. This means your research can be widely read and cited faster than in most other journals.
Highly ranked
STEM CELLS Translational Medicine has a 2023 Impact Factor of 5.4.
10+ years of impactful research in the community
In 2021, STEM CELLS Translational Medicine celebrated its 10th anniversary. The journal's sister journal, STEM CELLS® was first published in 1983 and was the first journal in the history of the entire field. 3 decades later at an ideal time when the stem cell field was maturing to a point where therapies were entering the realm of clinical translational, STEM CELLS Translational Medicine was created. Read the Editorial from Editor-in-Chief Anthony Atala on achieving this decade of impactful research.
Fully open access
All content published in STEM CELLS Translational Medicine is open access and freely available to individuals worldwide without a subscription. Readers who discover your article can click through to access the full content leading to many benefits including increased citation and usage, greater public engagement, wider potential collaboration, and faster impact on the community. Your institution may even pay for your open access charges; click here to learn more about our Read and Publish agreements with institutions and consortia.
Official journal of the Cord Blood Association
STEM CELLS Translational Medicine is the official journal of the Cord Blood Association (CBA). The CBA is an international nonprofit organization that promotes both public and family cord blood banking and accelerates the use of cord blood and perinatal tissues to benefit patients and advance medicine. For specific information on submitting cord blood research, visit our Call for Papers: Cord Blood page here.
Distinguished and diverse Editorial Board
Members of the Editorial Board of STEM CELLS Translational Medicine are recruited and appointed based on their expertise in the field and to provide geographic and demographic balance. They ensure that the journal publishes high-quality content, operates ethically, and provides a welcoming publishing outlet for authors from all background and at all stages of career. View the Editorial Board here.
Ready to submit?
Please refer to our instructions to authors for more information and our submission site if you are ready to submit. If you have any questions, email the Editorial Office at [email protected].
